{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T15:23:21Z","timestamp":1777217001260,"version":"3.51.4"},"reference-count":77,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00240","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T07:57:16Z","timestamp":1513929436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical and Biological Markers in Hypereosinophilic Syndromes"],"prefix":"10.3389","volume":"4","author":[{"given":"Paneez","family":"Khoury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Makiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy D.","family":"Klion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jaci.2015.03.004","article-title":"Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease","volume":"135","author":"Martin","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MPG.0b013e31828f1fd2","article-title":"PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity","volume":"57","author":"Franciosi","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/apt.13370","article-title":"Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity","volume":"42","author":"Safroneeva","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","article-title":"Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis","volume":"150","author":"Safroneeva","year":"2016","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jaci.2013.06.037","article-title":"Marked and persistent eosinophilia in the absence of clinical manifestations","volume":"133","author":"Chen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B7","first-page":"3693","article-title":"[So-called endocarditis lenta]","volume":"28","author":"Loeffler","year":"1952","journal-title":"Sem Hop"},{"key":"B8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-97-1-78","article-title":"NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations","volume":"97","author":"Fauci","year":"1982","journal-title":"Ann Intern Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"Chusid","year":"1975","journal-title":"Medicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(87)90412-0","article-title":"Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease","volume":"1","author":"Tai","year":"1987","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1212\/WNL.35.8.1140","article-title":"Peripheral neuropathy in hypereosinophilic syndrome","volume":"35","author":"Wichman","year":"1985","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJM198406213102501","article-title":"Episodic angioedema associated with eosinophilia","volume":"310","author":"Gleich","year":"1984","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s10620-015-3665-1","article-title":"Extracellular eosinophil granule protein deposition in ringed esophagus with sparse eosinophils","volume":"60","author":"Peterson","year":"2015","journal-title":"Dig Dis Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","article-title":"Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment","volume":"133","author":"Furuta","year":"2007","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/ajg.2017.202","article-title":"Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept","volume":"112","author":"Greuter","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa\u2019ad","year":"2011","journal-title":"Gastroenterology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40413-016-0094-3","article-title":"Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases","volume":"9","author":"Metcalfe","year":"2016","journal-title":"World Allergy Organ J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jim.2014.05.020","article-title":"Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins","volume":"411","author":"Makiya","year":"2014","journal-title":"J Immunol Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jaci.2010.06.038","article-title":"Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia","volume":"126","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.4049\/jimmunol.177.10.7340","article-title":"Major basic protein homolog (MBP2): a specific human eosinophil marker","volume":"177","author":"Plager","year":"2006","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jim.2012.06.011","article-title":"A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources","volume":"384","author":"Ochkur","year":"2012","journal-title":"J Immunol Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jaci.2013.11.024","article-title":"Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis","volume":"133","author":"Saffari","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2500\/ajra.2009.23.3357","article-title":"Eosinophil degranulation patterns in nasal polyposis: an ultrastructural study","volume":"23","author":"Armengot","year":"2009","journal-title":"Am J Rhinol Allergy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc1103005","article-title":"Eosinophil granule protein localization in eosinophilic endomyocardial disease","volume":"365","author":"Wright","year":"2011","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.cgh.2014.06.019","article-title":"Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study","volume":"12","author":"Dellon","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jlb.63.6.715","article-title":"Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes","volume":"63","author":"Sur","year":"1998","journal-title":"J Leukoc Biol"},{"key":"B33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jlb.52.6.611","article-title":"Eosinophil granule proteins in peripheral blood granulocytes","volume":"52","author":"Abu-Ghazaleh","year":"1992","journal-title":"J Leukoc Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3324\/haematol.2013.091264","article-title":"Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder","volume":"100","author":"Khoury","year":"2015","journal-title":"Haematologica"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/gutjnl-2012-303171","article-title":"The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis","volume":"62","author":"Furuta","year":"2013","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cgh.2014.06.026","article-title":"Accuracy, safety, and tolerability of tissue collection by cytosponge vs endoscopy for evaluation of eosinophilic esophagitis","volume":"13","author":"Katzka","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/ajg.2017.244","article-title":"Accuracy and safety of the cytosponge for assessing histologic activity in eosinophilic esophagitis: a two-center study","volume":"112","author":"Katzka","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ultrasmedbio.2014.09.017","article-title":"Non-invasive ultrasound to identify eosinophil granule proteins in eosinophilic esophagitis","volume":"41","author":"Saffari","year":"2015","journal-title":"Ultrasound Med Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1182\/blood-2003-11-3850","article-title":"Familial eosinophilia: a benign disorder?","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1056\/NEJMoa031261","article-title":"Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis","volume":"349","author":"Pl\u00f6tz","year":"2003","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/MCG.0000000000000621","article-title":"Longitudinal evaluation of noninvasive biomarkers for eosinophilic esophagitis","volume":"51","author":"Min","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1034\/j.1398-9995.2001.056008780.x","article-title":"Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age","volume":"56","author":"Breuer","year":"2001","journal-title":"Allergy"},{"key":"B43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0091-6749(00)90087-3","article-title":"Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity","volume":"105","author":"Pucci","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1067\/mai.2001.114246","article-title":"Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal","volume":"107","author":"L\u00f6nnkvist","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"S292","DOI":"10.1067\/mai.2000.110164","article-title":"Systemic activation of basophils and eosinophils: markers and consequences","volume":"106","author":"Bochner","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1007\/s10753-014-9926-x","article-title":"Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells","volume":"37","author":"Lingblom","year":"2014","journal-title":"Inflammation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaci.2011.05.032","article-title":"IL-5 receptor \u03b1 levels in patients with marked eosinophilia or mastocytosis","volume":"128","author":"Wilson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jaci.2008.02.033","article-title":"Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels","volume":"121","author":"Stein","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.rmed.2016.01.003","article-title":"Reductions in eosinophil biomarkers by benralizumab in patients with asthma","volume":"111","author":"Pham","year":"2016","journal-title":"Respir Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1182\/blood-2010-02-267542","article-title":"Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome","volume":"116","author":"Terrier","year":"2010","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/art.27678","article-title":"CCL17\/thymus and activation-related chemokine in Churg-Strauss syndrome","volume":"62","author":"Dallos","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","article-title":"Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome","volume":"67","author":"Khoury","year":"2012","journal-title":"Allergy"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/rheumatology\/keq445","article-title":"Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study","volume":"50","author":"Zwerina","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/rheumatology\/ken033","article-title":"Eotaxin-3 is involved in Churg-Strauss syndrome \u2013 a serum marker closely correlating with disease activity","volume":"47","author":"Polzer","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/ajg.2015.57","article-title":"Utility of a noninvasive serum biomarker panel for diagnosis and monitoring of eosinophilic esophagitis: a prospective study","volume":"110","author":"Dellon","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1111\/all.12311","article-title":"CD8(+) T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseases","volume":"68","author":"Stoeckle","year":"2013","journal-title":"Allergy"},{"key":"B57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ajh.2830500205","article-title":"Serum concentrations of IL-5, GM-CSF, and IL-3 and the production by lymphocytes in various eosinophilia","volume":"50","author":"Koike","year":"1995","journal-title":"Am J Hematol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/j.gastro.2013.08.046","article-title":"Molecular diagnosis of eosinophilic esophagitis by gene expression profiling","volume":"145","author":"Wen","year":"2013","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fmed.2017.00108","article-title":"Clinical applications of the eosinophilic esophagitis diagnostic panel","volume":"4","author":"Wen","year":"2017","journal-title":"Front Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.jaci.2012.01.060","article-title":"MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers","volume":"129","author":"Lu","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fmed.2017.00216","article-title":"(A Critical Appraisal of) Classification of Hypereosinophilic Disorders","volume":"4","author":"Kahn","year":"2017","journal-title":"Front. Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.iac.2007.07.002","article-title":"Lymphocytic variant hypereosinophilic syndromes","volume":"27","author":"Roufosse","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"B63","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1046\/j.1365-2141.2000.02097.x","article-title":"Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome","volume":"109","author":"Roufosse","year":"2000","journal-title":"Br J Haematol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia","volume":"341","author":"Simon","year":"1999","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000053723","article-title":"Clinical and immunological features of patients with interleukin-5-producing T cell clones and eosinophilia","volume":"124","author":"Simon","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/ejh.12842","article-title":"IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: a comparative case series","volume":"98","author":"Carruthers","year":"2017","journal-title":"Eur J Haematol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.06.006","article-title":"Hypereosinophilic syndrome subtype predicts responsiveness to glucocorticoids","author":"Khoury","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3109\/10428194.2014.976823","article-title":"Lymphocytic variant hypereosinophilic syndrome progressing to angioimmunoblastic T-cell lymphoma","volume":"56","author":"Roufosse","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/1521-4141(200104)31:4<1037::AID-IMMU1037>3.0.CO;2-#","article-title":"Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo","volume":"31","author":"de Lavareille","year":"2001","journal-title":"Eur J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1067\/mai.2002.127003","article-title":"High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome","volume":"110","author":"de Lavareille","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/blood-2007-07-100164","article-title":"Relapse following discontinuation of imatinib mesylate therapy for FIP1L1\/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing","volume":"110","author":"Klion","year":"2007","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/all.12843","article-title":"Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome","volume":"71","author":"Khoury","year":"2016","journal-title":"Allergy"},{"key":"B73","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3109\/10428194.2015.1065983","article-title":"Imatinib discontinuation for hypereosinophilic syndrome harboring theFIP1L1-PDGFRA transcript","volume":"57","author":"Helbig","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e3182a71eba","article-title":"The spectrum of FIP1L1-PDGFRA-associated chronic eosinophilic leukemia: new insights based on a survey of 44 cases","volume":"92","author":"Legrand","year":"2013","journal-title":"Medicine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.gastro.2010.09.037","article-title":"Mechanical properties of the esophagus in eosinophilic esophagitis","volume":"140","author":"Kwiatek","year":"2011","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cgh.2013.03.020","article-title":"Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis","volume":"11","author":"Nicod\u00e8me","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/rheumatology\/keu427","article-title":"Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Grayson","year":"2015","journal-title":"Rheumatology (Oxford)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00240\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T13:19:10Z","timestamp":1570540750000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00240\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":77,"alternative-id":["10.3389\/fmed.2017.00240"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00240","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]},"article-number":"240"}}